Cibc World Markets Corp Makes New Investment in Balchem Co. (NASDAQ:BCPC)

Cibc World Markets Corp purchased a new position in Balchem Co. (NASDAQ:BCPC - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 3,025 shares of the basic materials company's stock, valued at approximately $493,000.

A number of other institutional investors have also recently bought and sold shares of BCPC. Westside Investment Management Inc. acquired a new position in shares of Balchem in the 3rd quarter valued at $27,000. R Squared Ltd purchased a new position in shares of Balchem in the 4th quarter worth $29,000. Wilmington Savings Fund Society FSB acquired a new position in Balchem in the third quarter valued at $35,000. Venturi Wealth Management LLC purchased a new stake in Balchem during the fourth quarter valued at about $95,000. Finally, Smartleaf Asset Management LLC increased its stake in Balchem by 230.8% during the fourth quarter. Smartleaf Asset Management LLC now owns 645 shares of the basic materials company's stock worth $106,000 after acquiring an additional 450 shares during the last quarter. 87.91% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the company. StockNews.com lowered Balchem from a "buy" rating to a "hold" rating in a research note on Tuesday, February 25th. HC Wainwright reaffirmed a "buy" rating and issued a $190.00 target price on shares of Balchem in a research report on Monday, February 24th. Finally, Sidoti raised Balchem to a "hold" rating in a research report on Tuesday, February 25th.

Remove Ads

Balchem Stock Up 1.1 %

Shares of Balchem stock traded up $1.87 during trading hours on Wednesday, hitting $165.20. 115,715 shares of the company's stock traded hands, compared to its average volume of 114,742. Balchem Co. has a twelve month low of $137.69 and a twelve month high of $186.03. The company has a market cap of $5.37 billion, a PE ratio of 42.04, a PEG ratio of 4.41 and a beta of 0.63. The company has a quick ratio of 1.16, a current ratio of 1.99 and a debt-to-equity ratio of 0.19. The stock has a 50 day simple moving average of $164.97 and a 200-day simple moving average of $169.31.

Balchem (NASDAQ:BCPC - Get Free Report) last posted its quarterly earnings data on Friday, February 21st. The basic materials company reported $1.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.11 by ($0.08). Balchem had a return on equity of 11.37% and a net margin of 13.47%. The business had revenue of $240.00 million for the quarter, compared to analysts' expectations of $239.96 million. Equities research analysts anticipate that Balchem Co. will post 4.64 earnings per share for the current fiscal year.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.